|
This is getting ready to blast through $30. H1N1 scare will attract investors looking for a play on it outside the vaccine segment.
Sentiment : Buy Rating :
 (No ratings) |
34/Male |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
0.26